"Combined novel ultra-diluted bioactive formulation enhances Sodium Stibogluconate efficacy via T cell-mediated cytokine modulation in experimental visceral leishmaniasis".
The SSG-udLA combination represents a promising adjunctive therapeutic strategy for VL, providing enhanced antileishmanial efficacy, potent immunomodulation and improved safety over conventional monotherapy.